全文获取类型
收费全文 | 1032篇 |
免费 | 84篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 51篇 |
妇产科学 | 22篇 |
基础医学 | 90篇 |
口腔科学 | 45篇 |
临床医学 | 93篇 |
内科学 | 255篇 |
皮肤病学 | 17篇 |
神经病学 | 41篇 |
特种医学 | 109篇 |
外科学 | 132篇 |
综合类 | 42篇 |
预防医学 | 77篇 |
眼科学 | 26篇 |
药学 | 71篇 |
中国医学 | 1篇 |
肿瘤学 | 57篇 |
出版年
2023年 | 7篇 |
2022年 | 8篇 |
2021年 | 8篇 |
2020年 | 9篇 |
2019年 | 8篇 |
2018年 | 26篇 |
2017年 | 14篇 |
2016年 | 21篇 |
2015年 | 20篇 |
2014年 | 9篇 |
2013年 | 27篇 |
2012年 | 53篇 |
2011年 | 63篇 |
2010年 | 34篇 |
2009年 | 47篇 |
2008年 | 32篇 |
2007年 | 57篇 |
2006年 | 38篇 |
2005年 | 35篇 |
2004年 | 31篇 |
2003年 | 43篇 |
2002年 | 34篇 |
2001年 | 24篇 |
2000年 | 24篇 |
1999年 | 21篇 |
1998年 | 23篇 |
1997年 | 41篇 |
1996年 | 35篇 |
1995年 | 21篇 |
1994年 | 22篇 |
1993年 | 24篇 |
1992年 | 8篇 |
1991年 | 35篇 |
1990年 | 22篇 |
1989年 | 19篇 |
1988年 | 22篇 |
1987年 | 17篇 |
1986年 | 16篇 |
1985年 | 23篇 |
1984年 | 12篇 |
1983年 | 14篇 |
1982年 | 10篇 |
1981年 | 16篇 |
1980年 | 13篇 |
1979年 | 4篇 |
1978年 | 9篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1974年 | 5篇 |
1973年 | 5篇 |
排序方式: 共有1136条查询结果,搜索用时 15 毫秒
21.
Verweij J.; Wanders J.; Nielsen A. L.; Pavlidis N.; Calabresi F.; Huinink W. ten Bokkel; Bruntsch U.; Piccart M.; Franklin H.; Kaye S. B.; On behalf of the EORTC Early Clinical Trials Group 《Annals of oncology》1994,5(4):375-376
PURPOSE:: To test the antitumor activity of Elsamitrucin in metastaticcancer of the breast, colon and rectum, non-small cell lungand ovary. PATIENTS AND METHODS:: Eligibility required histologically proven cancer. Patientswith colorectal or non-small cell lung cancer could not havereceived prior chemotherapy. Patients were entered if WHO PSwas 2 and organ functions were normal. Treatment consisted ofElsamitrucin 25 mg/m2/week given as a 510 min infusionfor at least 36 weekly doses. RESULTS:: One hundred and five patients entered the studies, 97 were eligible,94 are evaluable for toxicity and 75 for response. Toxicitymainly consisted of mild nausea/vomiting, and less frequentlyreversible hepatotoxicity and malaise. No objective responseswere seen. CONCLUSION:: Elsamitrucin at this dose and schedule is not an active drugin metastatic breast cancer, colorectal cancer, non-small celllung cancer or ovarian cancer. Elsamitrucin, phase II, breast, colorectum, nonsmall cell lung, ovary 相似文献
22.
23.
24.
25.
26.
27.
28.
29.
OBJECTIVES: Selenium is a trace mineral that, as a constituent of certain selenoproteins, acts as an antioxidant. Results of studies addressing a cancer protective effect of selenium have been controversial. The present study measured selenoprotein-P, extracellular glutathione peroxidase, and plasma selenium in patients with colon cancer and adenomatous colon polyps to determine whether patients who develop colorectal adenomas or cancer are selenium deficient. METHODS: Patients who presented to an endoscopy center for colonoscopy or who were referred to our institution with a newly diagnosed colorectal cancer were offered enrollment in the trial. Each patient underwent phlebotomy, usually immediately after colonoscopy. In all, 103 patients were enrolled in the study. Of these, 33 patients were found to have colorectal cancer, 35 adenomatous colon polyps, and 17 normal examinations. A total of 18 patients had other diagnoses and were not included in the study group. RESULTS: The mean age for the colorectal cancer group was 69 yr, for the adenomatous colon polyp group 62 yr, and for the normal group was 56 yr. The adenomatous colon polyp and normal groups were predominantly female. Based on one way analysis of variance tests, there was no significant difference in selenoprotein-P or plasma selenium levels or extracellular glutathione peroxidase activity among the three groups (p = 0.28, 0.098, and 0.35 respectively). CONCLUSIONS: The present data suggest that patients with adenomatous colon polyps and those with colorectal cancer are not selenium deficient. 相似文献
30.
Permanent diabetes mellitus in the first year of life 总被引:5,自引:0,他引:5
Iafusco D Stazi MA Cotichini R Cotellessa M Martinucci ME Mazzella M Cherubini V Barbetti F Martinetti M Cerutti F Prisco F;Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology Diabetology 《Diabetologia》2002,45(6):798-804
AIMS/HYPOTHESIS: The pathogenesis of permanent diabetes mellitus diagnosed early in life is heterogeneous and, in most cases, not known. We aimed at identifying markers differentiating between non-autoimmune and autoimmune diabetes. METHODS: The clinical, genetic and epidemiological features of 111 diabetic patients (62 males) who received insulin within 12 months of life were studied. RESULTS: The epidemic curve by age of diabetes onset revealed two subsets of patients at a cutoff of 180 days. In the group with diabetes onset before 180 days ("early onset" permanent diabetes) the analysis of HLA susceptibility heterodimers (available for 21 individuals) showed that 76% had a "protective" HLA genotype for Type I (insulin-dependent) diabetes mellitus as compared to 11.9% (5/42) of the later onset group. Accordingly, "early onset" children were less likely to have autoimmunity markers (4 out of 26 tested) than children with onset after 180 days (13 out 20 tested) (15.4% vs. 65.0%, p<0.01). Of note, 19 out of 20 (or the 95%) patients who were born on the island of Sardinia, an Italian region where the incidence of Type I diabetes is six times higher than continental Italy (33/100,000/year vs 5/100,000/year), were included in the later onset group (>180 days). Small-for-date birthweight, a possible sign of reduced foetal insulin secretion, was more common in the "early onset" group (OR=9.9, 95%-CI 2.6-38.6). CONCLUSION/INTERPRETATION: These results, obtained in the largest population-based cohort of diabetic infants hitherto reported, suggest that "early onset" permanent diabetes cases differ from later onset cases and that most of them do not have an autoimmune pathogenesis. 相似文献